To screen or not to screen for pre-type 1 diabetes?

Desmond Schatz, Jeffrey Krischer, Jin-Xiong She

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The incidence of type 1 diabetes is increasing worldwide and the disease is an onerous burden both to the individual and to society. There are thus important reasons to screen for the disease before it becomes manifest: (1) to improve understanding of the natural history of the prediabetic period; (2) to gain further insights into the immunopathogenesis of the disease; (3) to identify individuals for prevention trials; (4) to make an earlier diagnosis in order to reduce morbidity and mortality. Great strides have been made, yet there is still a great deal to be learned. Opponents of screening argue that screening tests for the disease have a low positive predictive value and that predicting the disease without a primary prevention capability raises ethical considerations because of induced stress, lifestyle changes, cost and potential effects on insurability. The greatest single barrier against large-scale population screening and prevention of the disease remains the lack of an effective intervention. However, screening in the context of well-designed research studies must continue - ultimately the benefit to the individual and to society will be immense.

Original languageEnglish (US)
Pages (from-to)12-17
Number of pages6
JournalHormone Research
Volume57
Issue numberSUPPL. 1
DOIs
StatePublished - May 11 2002
Externally publishedYes

Fingerprint

Type 1 Diabetes Mellitus
Primary Prevention
Natural History
Life Style
Early Diagnosis
Morbidity
Costs and Cost Analysis
Mortality
Incidence
Research
Population

Keywords

  • Diabetes prevention
  • Diabetes screening
  • Immunopathogenesis
  • Prediabetic period
  • Type 1 diabetes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

To screen or not to screen for pre-type 1 diabetes? / Schatz, Desmond; Krischer, Jeffrey; She, Jin-Xiong.

In: Hormone Research, Vol. 57, No. SUPPL. 1, 11.05.2002, p. 12-17.

Research output: Contribution to journalArticle

Schatz, Desmond ; Krischer, Jeffrey ; She, Jin-Xiong. / To screen or not to screen for pre-type 1 diabetes?. In: Hormone Research. 2002 ; Vol. 57, No. SUPPL. 1. pp. 12-17.
@article{5dd503d15ea747b9b3ee79cc19cd3214,
title = "To screen or not to screen for pre-type 1 diabetes?",
abstract = "The incidence of type 1 diabetes is increasing worldwide and the disease is an onerous burden both to the individual and to society. There are thus important reasons to screen for the disease before it becomes manifest: (1) to improve understanding of the natural history of the prediabetic period; (2) to gain further insights into the immunopathogenesis of the disease; (3) to identify individuals for prevention trials; (4) to make an earlier diagnosis in order to reduce morbidity and mortality. Great strides have been made, yet there is still a great deal to be learned. Opponents of screening argue that screening tests for the disease have a low positive predictive value and that predicting the disease without a primary prevention capability raises ethical considerations because of induced stress, lifestyle changes, cost and potential effects on insurability. The greatest single barrier against large-scale population screening and prevention of the disease remains the lack of an effective intervention. However, screening in the context of well-designed research studies must continue - ultimately the benefit to the individual and to society will be immense.",
keywords = "Diabetes prevention, Diabetes screening, Immunopathogenesis, Prediabetic period, Type 1 diabetes",
author = "Desmond Schatz and Jeffrey Krischer and Jin-Xiong She",
year = "2002",
month = "5",
day = "11",
doi = "10.1159/000053306",
language = "English (US)",
volume = "57",
pages = "12--17",
journal = "Hormone Research in Paediatrics",
issn = "1663-2818",
publisher = "S. Karger AG",
number = "SUPPL. 1",

}

TY - JOUR

T1 - To screen or not to screen for pre-type 1 diabetes?

AU - Schatz, Desmond

AU - Krischer, Jeffrey

AU - She, Jin-Xiong

PY - 2002/5/11

Y1 - 2002/5/11

N2 - The incidence of type 1 diabetes is increasing worldwide and the disease is an onerous burden both to the individual and to society. There are thus important reasons to screen for the disease before it becomes manifest: (1) to improve understanding of the natural history of the prediabetic period; (2) to gain further insights into the immunopathogenesis of the disease; (3) to identify individuals for prevention trials; (4) to make an earlier diagnosis in order to reduce morbidity and mortality. Great strides have been made, yet there is still a great deal to be learned. Opponents of screening argue that screening tests for the disease have a low positive predictive value and that predicting the disease without a primary prevention capability raises ethical considerations because of induced stress, lifestyle changes, cost and potential effects on insurability. The greatest single barrier against large-scale population screening and prevention of the disease remains the lack of an effective intervention. However, screening in the context of well-designed research studies must continue - ultimately the benefit to the individual and to society will be immense.

AB - The incidence of type 1 diabetes is increasing worldwide and the disease is an onerous burden both to the individual and to society. There are thus important reasons to screen for the disease before it becomes manifest: (1) to improve understanding of the natural history of the prediabetic period; (2) to gain further insights into the immunopathogenesis of the disease; (3) to identify individuals for prevention trials; (4) to make an earlier diagnosis in order to reduce morbidity and mortality. Great strides have been made, yet there is still a great deal to be learned. Opponents of screening argue that screening tests for the disease have a low positive predictive value and that predicting the disease without a primary prevention capability raises ethical considerations because of induced stress, lifestyle changes, cost and potential effects on insurability. The greatest single barrier against large-scale population screening and prevention of the disease remains the lack of an effective intervention. However, screening in the context of well-designed research studies must continue - ultimately the benefit to the individual and to society will be immense.

KW - Diabetes prevention

KW - Diabetes screening

KW - Immunopathogenesis

KW - Prediabetic period

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=0036242426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036242426&partnerID=8YFLogxK

U2 - 10.1159/000053306

DO - 10.1159/000053306

M3 - Article

VL - 57

SP - 12

EP - 17

JO - Hormone Research in Paediatrics

JF - Hormone Research in Paediatrics

SN - 1663-2818

IS - SUPPL. 1

ER -